J. Dougherty

发表

High Rate of Recombination throughout the Human Immunodeficiency Virus Type 1 Genome

A. Jetzt, Hong-xia Yu, G. Klarmann, 2000, Journal of Virology.

A spleen necrosis virus-based retroviral vector which expresses two genes from a dicistronic mRNA.

Y. Ron, J. Dougherty, R. Kaufman, 1992, Virology.

Human Immunodeficiency Virus Type 1 Recombination: Rate, Fidelity, and Putative Hot Spots

A. Jetzt, G. Klarmann, Y. Ron, 2002, Journal of Virology.

Rapid hybridization kinetics of DNA attached to submicron latex particles.

J. Dougherty, S. Wolf, L. Haines, 1987, Nucleic acids research.

Immobilization of DNA via oligonucleotides containing an aldehyde or carboxylic acid group at the 5' terminus.

J. Dougherty, J. Kremsky, J. Wooters, 1987, Nucleic acids research.

Global Analysis of Pub1p Targets Reveals a Coordinate Control of Gene Expression through Modulation of Binding and Stability

Patricia Soteropoulos, Bin Tian, Joseph P. Dougherty, 2005, Molecular and Cellular Biology.

The mouse immunoglobulin heavy-chain gene enhancer contains sequences that inhibit transcription in vitro in HeLa cell extracts

P. Chambon, J. Dougherty, P. Augereau, 1986, Molecular and cellular biology.

Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors

J. Dougherty, P. Thota, M. Adelson, 2003, Hepatology.

High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector

Y. Ron, J. Dougherty, C. Prorock, 1993, Journal of virology.

INTERFERON ACTION: CLONING OF cDNA SEGMENTS COMPLEMENTARY TO MESSENGER RNAs INDUCED BY INTERFERONS

P. Lengyel, J. Dougherty, M. Brawner, 1982 .

DOUBLE‐STRANDED RNA AND THE ENZYMOLOGY OF INTERFERON ACTION *

P. Lengyel, J. Dougherty, P. Farrell, 1980, Annals of the New York Academy of Sciences.

Reaction mechanism of Ca2+-dependent ATP hydrolysis by skeletal muscle sarcoplasmic reticulum in the absence of added alkali metal salts. I. Characterization of steady state ATP hydrolysis and comparison with that in the presence of KCl.

A. Katz, J. Dougherty, M. Shigekawa, 1978, The Journal of biological chemistry.

Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations.

Y. Ron, J. Dougherty, Chiann-Chyi Chen, 2001, International immunology.

Inhibition of Ly-6A antigen expression prevents T cell activation

Y. Ron, J. Dougherty, P. Flood, 1990, The Journal of experimental medicine.

Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis

J. Sprent, Y. Ron, J. Dougherty, 1992, Journal of Neuroimmunology.

Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis.

Y. Ron, J. Dougherty, K. Myers, 1995, Journal of neuroimmunology.

Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency

Y. Ron, J. Dougherty, Chiann-Chyi Chen, 2010, Autoimmunity.

Mutations of conserved cysteine residues in the CWLC motif of the oncoretrovirus SU protein affect maturation and translocation.

Y. Ron, J. Dougherty, A. Varela-Echavarría, 1995, Virology.

A murine model for B-lymphocyte somatic cell gene therapy.

Y. Ron, J. Dougherty, M. Kuo, 1994, Proceedings of the National Academy of Sciences of the United States of America.

A gene therapy approach for treating T-cell-mediated autoimmune diseases.

Y. Ron, J. Dougherty, A. Rivera, 2001, Blood.

Efficient gene transfer into primary murine lymphocytes obviating the need for drug selection.

Y. Ron, J. Dougherty, M. Kuo, 1993, Blood.

Host stem cells can selectively reconstitute missing lymphoid lineages in irradiation bone marrow chimeras.

Y. Ron, J. Dougherty, A. Ben-nun, 2003, Blood.

Spleen necrosis virus, an avian retrovirus, can infect primate cells

Y. Ron, J. Dougherty, H. Koo, 1991, Journal of virology.

3′-Deoxy-2′-phosphoramidites of adenosine and 5-methyluridine used for the solid phase synthesis of unnatural 3′-deoxy-2′–5″-Oligonucleotides.

J. Dougherty, C. Rizzo, R. Breslow, 1992 .

Oligodeoxynucleotides that contain 2',5'' linkages: synthesis and hybridization properties

J. Dougherty, C. Rizzo, R. Breslow, 1992 .

In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis.

Y. Ron, J. Dougherty, K. Myers, 1993, Journal of immunology.

Reticuloendotheliosis type C and primate type D oncoretroviruses are members of the same receptor interference group

Y. Ron, J. Dougherty, H. Koo, 1992, Journal of virology.

Studies with pure mouse Ehrlich ascites tumor interferons alpha and beta: patterns of induction of (2'-5') (A)n synthetase and of a double-stranded RNA-dependent protein kinase in mouse cells and human cells.

P. Lengyel, J. Dougherty, R. Broeze, 1981, Journal of interferon research.

Isolation of a cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein.

J. Dougherty, R. Kriz, J. Floros, 1987, The Journal of biological chemistry.

Orally bioavailable acyclic nucleoside phosphonate prodrugs: Adefovir dipivoxil and bis(POC)PMPA

J. Dougherty, K. Cundy, N. Bischofberger, 1999 .

TheMouseImmunoglobulin Heavy-Chain GeneEnhancer Contains Sequences ThatInhibit Transcription InVitro inHeLaCellExtracts

J. Dougherty, 1986 .

N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivo.

J. Dougherty, S. Krawczyk, S. Swaminathan, 1998, Journal of medicinal chemistry.

Toward the Development of a Virus-Cell-Based Assay for the Discovery of Novel Compounds against Human Immunodeficiency Virus Type 1

S. Peltz, Y. Ron, J. Dougherty, 2003, Antimicrobial Agents and Chemotherapy.

HIV Type-1 Latency: Targeted Induction of Proviral Reservoirs

S. Peltz, J. Dougherty, Z. Gu, 2009, Antiviral chemistry & chemotherapy.

Use of single-cycle analysis to study rates and mechanisms of retroviral mutation.

A. Jetzt, J. Dougherty, H. Yu, 1997, Methods.

Inducible human immunodeficiency virus type 1 packaging cell lines

Y. Ron, J. Dougherty, A. Rabson, 1996, Journal of virology.

Pharmaceutical therapies to recode nonsense mutations in inherited diseases.

J. Dougherty, H. Lee, 2012, Pharmacology & therapeutics.

Post-transcriptionally Regulated Expression System in Human Xenogeneic Transplantation Models.

Y. Ron, J. Dougherty, Chiann-Chyi Chen, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Human Immunodeficiency Virus Type 1 Latency Model for High-Throughput Screening

S. Peltz, Y. Ron, J. Dougherty, 2005, Antimicrobial Agents and Chemotherapy.

Interferon, double-stranded RNA, and RNA degradation. Isolation of homogeneous pppA(2'p5'A)n-1 synthetase from Ehrlich ascites tumor cells.

P. Lengyel, J. Dougherty, P. Farrell, 1980, The Journal of biological chemistry.

Interferons, double-stranded RNA, and RNA degradation. Isolation and characterization of homogeneous human (2'-5')(a)n synthetase.

P. Lengyel, J. Dougherty, R. Broeze, 1981, The Journal of biological chemistry.

Synthesis of (2'-5')(A)n from ATP. Characteristics of the reaction catalyzed by (2'-5')(A)n synthetase purified from mouse Ehrlich ascites tumor cells treated with interferon.

P. Lengyel, J. Dougherty, H. Samanta, 1980, The Journal of biological chemistry.

A newly discovered function for RNase L in regulating translation termination

S. Peltz, J. Dougherty, C. Bisbal, 2005, Nature Structural &Molecular Biology.

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication

Y. Ron, J. Dougherty, Chiann-Chyi Chen, 2013, Retrovirology.

Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications

Y. Ron, B. Preston, J. Dougherty, 1995, Journal of virology.

A peripheral blood-derived monolayer supports long-term cultures of human CD4+ and CD8+ T lymphocytes.

Y. Ron, J. Dougherty, M. Kuo, 1995, Blood.

Discontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free system

G. Klarmann, B. Preston, J. Dougherty, 1997, Journal of virology.

Bothanti-CD11a(LFA-l) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis

Y. Ron, J. Dougherty, K. Myers, 1995, Journal of Neuroimmunology.

Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen.

Y. Ron, J. Dougherty, Chiann-Chyi Chen, 2004, Blood.

Long-Term Contribution to the Myeloid Compartment by Lineage-Committed Stem Cells

Y. Ron, J. Dougherty, Chiann-Chyi Chen, 1998 .

Long-term contribution to the myeloid compartment by lineage-committed stem cells.

Y. Ron, J. Dougherty, A. Rivera, 1998, Blood.

Mutational Analysis of HIV-1 Long Terminal Repeats to Explore the Relative Contribution of Reverse Transcriptase and RNA Polymerase II to Viral Mutagenesis*

Hong Yu, Y. Ron, B. Preston, 2002, The Journal of Biological Chemistry.

The Nature of Human Immunodeficiency Virus Type 1 Strand Transfers*

A. Jetzt, Hong-xia Yu, Y. Ron, 1998, The Journal of Biological Chemistry.

Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences.

Y. Ron, J. Dougherty, M. Kaul, 1998, Virology.

A HIV-2-based self-inactivating vector for enhanced gene transduction.

Y. Ron, J. Dougherty, S. Mukherjee, 2007, Journal of biotechnology.

Choice and use of appropriate packaging cell types.

J. Dougherty, S. Mukherjee, A. L. Pacchia, 2003, Methods in molecular biology.

An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.

Y. Ron, J. Dougherty, M. Adelson, 2001, Virology.

Identification of a Cellular Factor That Modulates HIV-1 Programmed Ribosomal Frameshifting*

S. Peltz, J. Dougherty, Jianling Zhuang, 2010, The Journal of Biological Chemistry.

The Human Immunodeficiency Virus Type 1 Ribosomal Frameshifting Site Is an Invariant Sequence Determinant and an Important Target for Antiviral Therapy

S. Peltz, J. Dougherty, Xi Jiang, 2004, Journal of Virology.

Transduction of Cellular Sequence by a Human Immunodeficiency Virus Type 1-Derived Vector

Y. Ron, B. Preston, J. Dougherty, 2001, Journal of Virology.

A murine model for genetic manipulation of the T cell compartment.

Y. Ron, J. Dougherty, M. Kuo, 1996, Experimental hematology.

Stimulation of in vitro transcription from heterologous promoters by

P. Chambon, J. Dougherty, P. Sassone-Corsi, 1984 .

Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma.

J. Dougherty, L. Edelstein, S. Micheva-Viteva, 2009, AIDS research and human retroviruses.

The thermal stability of oligonucleotide duplexes is sequence independent in tetraalkylammonium salt solutions: application to identifying recombinant DNA clones.

J. Dougherty, E. Fritsch, R. Rudersdorf, 1988, Nucleic acids research.

A nickel chelate microtiter plate assay for six histidine-containing proteins.

C. Gibbs, J. Dougherty, L. Paborsky, 1996, Analytical biochemistry.

Stimulation of in vitro transcription from heterologous promoters by the simian virus 40 enhancer.

P. Chambon, J. Dougherty, B. Wasylyk, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Antisense Translates into Sense

S. Peltz, J. Dougherty, 1999, The Journal of experimental medicine.

Proviral Progeny of Heterodimeric Virions Reveal a High Crossover Rate for Human Immunodeficiency Virus Type 2

Y. Ron, J. Dougherty, S. Mukherjee, 2006, Journal of Virology.

Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4+ T cells

J. Dougherty, C. Gélinas, Yoshifumi Kobayashi, 2017, The Journal of general virology.

J. Dougherty, Yoshifumi Kobayashi, elinas, 2017 .

Reaction mechanism of Ca2+-dependent ATP hydrolysis by skeletal muscle sarcoplasmic reticulum in the absence of added alkali metal salts. III. Sequential occurrence of ADP-sensitive and ADP-insensitive phosphoenzymes.

J. Dougherty, M. Shigekawa, 1978, The Journal of biological chemistry.

Reaction mechanism of Ca2+-dependent ATP hydrolysis by skeletal muscle sarcoplasmic reticulum in the absence of added alkali metal salts. II. Kinetic properties of the phosphoenzyme formed at the steady state in high Mg2+ and low Ca2+ concentrations.

J. Dougherty, M. Shigekawa, 1978, The Journal of biological chemistry.

Some kinetic properties of phosphorylated ATPase of sarcoplasmic reticulum formed in the absence of added alkali metal salts.

J. Dougherty, M. Shigekawa, 1977, Biochemical and biophysical research communications.

1 The translational landscape of SARS-CoV-2 and infected cells 1 2 3

J. Dougherty, S. Brody, A. Horani, 2020 .

High Rate of Genetic Recombination in Murine Leukemia Virus: Implications for Influencing Proviral Ploidy

Y. Ron, J. Dougherty, Jianling Zhuang, 2006, Journal of Virology.

Pseudotyped REV/SRV retroviruses reveal restrictions to infection and host range within members of the same receptor interference group.

Y. Ron, J. Dougherty, H. Koo, 1994, Virology.

High-throughput Screening Uncovers a Compound That Activates Latent HIV-1 and Acts Cooperatively with a Histone Deacetylase (HDAC) Inhibitor*

S. Peltz, Y. Ron, J. Dougherty, 2011, The Journal of Biological Chemistry.

The effect of febrile temperatures on biologic actions of interferons: abrogation of suppression of delayed-type hypersensitivity and antibody production.

Y. Ron, J. Dougherty, G. Duff, 1984, Journal of Immunology.

Synthesis, in Vitro Biological Evaluation and Oral Bioavailability of 9-[2-(Phosphonomethoxy)Propyl]Adenine (PMPA) Prodrugs

J. Dougherty, J. Shaw, R. Oliyai, 1997 .

Mechanisms of retroviral mutation.

B. Preston, J. Dougherty, J. Dougherty, 1996, Trends in microbiology.

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication

Y. Ron, J. Dougherty, Chiann-Chyi Chen, 2013, Retrovirology.